157 related articles for article (PubMed ID: 33050233)
1. Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma.
Park H; Park J; Choi MS; Kim J; Kim H; Shin JH; Kim JH; Kim JS; Kim SW; Chung JH; Kim TH
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050233
[TBL] [Abstract][Full Text] [Related]
2. Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma.
Bae SY; Jung SP; Choe JH; Kim JS; Kim JH
Kaohsiung J Med Sci; 2019 Dec; 35(12):772-777. PubMed ID: 31483088
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer.
Kim H; Park SY; Choe JH; Kim JS; Hahn SY; Kim SW; Chung JH; Jung J; Kim TH
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32182688
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma.
Park H; Park SY; Park J; Choe JH; Chung MK; Woo SY; Choi JY; Kim SW; Chung JH; Kim TH
Front Endocrinol (Lausanne); 2021; 12():749973. PubMed ID: 34675884
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of neutrophil-to-lymphocyte ratio and calcitonin concentration for predicting lymph node metastasis and distant metastasis in patients with medullary thyroid cancer.
Xu N; Jian Y; Wang Y; Tian W
Mol Clin Oncol; 2018 Dec; 9(6):629-634. PubMed ID: 30546892
[TBL] [Abstract][Full Text] [Related]
6. A nomogram to predict lateral lymph node metastases in lateral neck in patients with medullary thyroid cancer.
Jin L; Zhang X; Ni S; Yan D; Wang M; Li Z; Liu S; An C
Front Endocrinol (Lausanne); 2022; 13():902546. PubMed ID: 36051385
[TBL] [Abstract][Full Text] [Related]
7. Does shear wave elastography for medullary thyroid carcinoma predict lateral cervical lymph node metastasis?
Wen X; Li B; Yu X; Huang Y; Cheng W; Su Z
Eur J Radiol; 2022 Jan; 146():110079. PubMed ID: 34864615
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
9. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
10. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Machens A; Dralle H
J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
[TBL] [Abstract][Full Text] [Related]
11. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
[TBL] [Abstract][Full Text] [Related]
12. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
13. Combination of ultrasound and serological tests for detecting occult lateral lymph node metastases in medullary thyroid cancer.
Xiao J; Jiang J; Chen W; Hong T; Li B; He X; Liu W
Cancer Med; 2023 May; 12(10):11417-11426. PubMed ID: 37004158
[TBL] [Abstract][Full Text] [Related]
14. The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway.
Opsahl EM; Akslen LA; Schlichting E; Aas T; Brauckhoff K; Hagen AI; Rosenlund AF; Sigstad E; Grøholt KK; Jørgensen LH; Bjøro T
Eur Thyroid J; 2019 Jun; 8(3):159-166. PubMed ID: 31259158
[TBL] [Abstract][Full Text] [Related]
15. Single center experience in primary surgery for medullary thyroid carcinoma.
Ukkat J; Gimm O; Brauckhoff M; Bilkenroth U; Dralle H
World J Surg; 2004 Dec; 28(12):1271-4. PubMed ID: 15517488
[TBL] [Abstract][Full Text] [Related]
16. Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.
Bohec H; Breuskin I; Hadoux J; Schlumberger M; Leboulleux S; Hartl DM
World J Surg; 2019 Mar; 43(3):818-823. PubMed ID: 30465086
[TBL] [Abstract][Full Text] [Related]
17. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
18. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Aug; 99(8):2986-94. PubMed ID: 24840813
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
20. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified?
Gimm O; Dralle H
Surgery; 1997 Dec; 122(6):1124-30; discussion 1130-1. PubMed ID: 9426428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
